7th International Cancer Congress
The 7th International Cancer Congress (ICC2025) is the Binaytara Foundation's 7th annual oncology conference in Janakpurdham, Nepal.
Category
- Cancer Dis...See more
Format
- Conference / meeting
Credits
Event date March 21, 2025
Cost $150.00
Best of Hematology and Breast Cancer 2025, Coeur d'Alene
The Best of Hematology and Breast Cancer 2025 conference in Coeur d'Alene is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
Best of Hematology and Breast Cancer 2025, Des Moines
The Best of Hematology and Breast Cancer 2025 conference in Des Moines is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.
Central Illinois Hematology Oncology Conference
The Central Illinois Hematology Oncology Conference is an accredited continuous education to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology.
2025 Nebraska Congress on Hematologic Malignancies: Recent Advances and Cellular Therapy
The 2025 Nebraska Congress on Hematologic Malignancies: Recent Advances and Cellular Therapy is a one-day CME-accredited, in-person conference that convenes leading experts to discuss the latest advances in the management of benign and malignant hematologic disorders.
Case-Based Insights on Hematologic Malignancies
The Case-Based Insights on Hematologic Malignancies Conference is a CME-accredited, in-person hematology conference featuring leading hematology experts.
Category
- Hematologic Malignancies
Format
- Conference / meeting
Credits
- 6.00 ABIM ...See more
Event date May 3, 2025
Cost $150.00
North Carolina Hematologic Malignancies Symposium
The North Carolina Hematologic Malignancies Symposium aims to enhance participants’ knowledge and competence in applying practice-changing clinical data and expert recommendations to optimize outcomes for patients with hematologic malignancies.
2025 Seattle Cellular Therapy Summit
This CME-accredited activity, 2025 Seattle Cellular Therapy Summit, features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of c